Leader in women’s health to showcase clinically proven solutions across the continuum of breast and skeletal health at annual meeting
MARLBOROUGH, Mass.–(BUSINESS WIRE)–#HOLX–Hologic, Inc. (Nasdaq: HOLX) will showcase its extensive portfolio of breast and skeletal health products, including screening and diagnostics solutions, breast biopsy, and breast cancer treatment and monitoring solutions, at the 107th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 28 to Dec. 2.
On-site at McCormick Place, in the South Hall in Booth #2511, Hologic will offer attendees opportunities to engage with products, including the Dimensions® mammography portfolio, Mach™ ultrasound systems, and a full suite of breast biopsy and surgery solutions. Additionally, the Company will host a series of both CME and non-CME accredited medical education symposiums and lunch-and-learn sessions, accessible to attendees on-site and from remote locations.
“We’re excited to provide our attendees hands-on experiences with our category-leading innovations, both in our booth and during our medical sessions, as we explore the future of breast health at RSNA 2021,” said Jennifer Meade, Hologic’s Division President, Breast and Skeletal Health Solutions. “Our commitment to delivering clinically proven solutions across the continuum of care to improve outcomes, reduce costs and increase patient satisfaction remains steadfast, and we’re ready to bring that commitment to life through our comprehensive programming at this year’s meeting both in-person and virtually.”
Medical sessions and symposia taking place throughout the event include:
For more information on Hologic’s RSNA 2021 offerings or to RSVP for a medical education session, please visit www.HologicVirtual.com.
About Hologic, Inc.
Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.
Hologic, 3DQuorum, Dimensions, Mach, ShearWave and The Science of Sure are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.
Forward-Looking Statements
This news release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic products. There can be no assurance these products will achieve the benefits described herein or that such benefits will be replicated in any particular manner with respect to an individual patient, as the actual effect of the use of the products can only be determined on a case-by-case basis. In addition, there can be no assurance that these products will be commercially successful or achieve any expected level of sales. Hologic expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such data or statements are based.
This information is not intended as a product solicitation or promotion where such activities are prohibited. For specific information on what products are available for sale in a particular country, please contact a local Hologic sales representative or write to womenshealth@hologic.com.
SOURCE: Hologic, Inc.
Contacts
Media Contact:
Jane Mazur
508.263.8764 (direct)
585.355.5978 (mobile)
jane.mazur@hologic.com
Investor Contacts:
Michael Watts (direct)
858.410.8588
michael.watts@hologic.com
Ryan Simon (direct)
858.410.8514
ryan.simon@hologic.com
Well-Capitalized Combined Company with Strong Financial Profile and 2023 Revenue of $246M, 28% from Recurring…
Chowis Co. Ltd. Skin, Hair and Scalp Solutions Provider Signs Agreement with Kolmar Korea to…
PORTLAND, OR / ACCESSWIRE / July 3, 2024 / Rose Villa Senior Living continues to…
Highlights:Total revenue of $9.9 million for Q1 2025, reflecting YoY growth of 31% from the…
Medical Device Developer & Investor Taps 4 Markets With Growth Projections of USD $39.1B by…
The round is led by Danish VC Dreamcraft, together with biotech investor Lundbeckfonden BioCapital and…